Despite a challenging fiscal year, Carl Zeiss Meditec AG (CZMWF) leverages new product launches and strategic market ...

Fan violence at a soccer match in Germany left 79 people injured on Saturday, local police said. Supporters of FC Carl Zeiss ...

I've made no secret about my liking for the MedTech company Carl Zeiss Meditec (OTCPK:CZMWF). This is, to my mind one of the best companies in MedTech not only due to the company's portfolio ...

There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

The Carl Zeiss Foundation is contributing EUR 6 million to a research project on the regeneration of the nervous system at ...

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology ...

Net income: €178.7m (down 39% from FY 2023). Profit margin: 8.7% (down from 14% in FY 2023). The decrease in margin was ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

RBC Capital analyst Jack Reynolds-Clark maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report) today and set a price target of €70.00. The company’s shares closed yesterday at €58.93.

ZEISS Industrial Quality Solutions, the global leader in cutting-edge metrology and inspection technologies and software, ...